Glucagon signalling deficiency syndromes, as exhibited by patients with Mahvash disease, GCGR−/− mice and pharmacological blockade of GCGR, are notable for very high plasma levels of glucagon and amino acids. Here, GCG is linked to GCGR-related hyperglucagonemia.